Research!America

By Peter W. Kalivas, PhD, President of the American College of Neuropsychopharmacology. Dr. Kalivas is Professor and Chair, Department of Neurosciences at the Medical University of South Carolina. The American College of Neuropsychopharmacology (ACNP), founded in 1961, is the nation’s premier professional society in brain, behavior, and neuropharmacology research. The field of neuropsychopharmacology involves evaluating the effects of natural and synthetic compounds upon the brain, mind, and human behavior, and the ACNP serves as a forum for advancing the latest discoveries about the brain towards cures for neuropsychiatric diseases. The core purpose of the ACNP is to catalyze and advance...
By Margaret Foti, PhD, MD (h.c.), Chief Executive Officer, American Association for Cancer Research Each year, the American Association for Cancer Research (AACR) is pleased to support and highlight May as National Cancer Research Month. Throughout this special month, the AACR celebrates the accomplishments of the scientific community, advocates for funding increases for the National Institutes of Health (NIH) and the National Cancer Institute (NCI), and spotlights the need for continued improvements in patient care. There’€™s no doubt that tremendous progress has been made against cancer. People who have been diagnosed with cancer are living longer today than ever before. The five-year...
Letter to the editor by Research!America VP of Communications Suzanne Ffolkes published in The New York Times in response to article, ’€œ Labs Are Told to Start Including a Neglected Variable: Females ’€ (May 14, 2014) In addressing gender bias in biomedical and clinical research, it’€™s also important to close gaps in clinical trial participation among minorities to understand how different segments of the population respond to various treatments. When asked if they or someone in their family had ever participated in a trial, only 17 percent of Hispanics, 15 percent of African-Americans and 11 percent of Asian-Americans said yes in polling commissioned by Research!America, a nonprofit...
Dear Research Advocate: Congress continues to pay particular attention to – and make decisions bearing on – the pace of medical progress. To briefly count the ways: The Senate Labor-HHS Appropriations subcommittee heard testimony yesterday from agency heads within HHS about the significance of health-related spending, including spending on medical and health research. Read our written testimony here . Congressman Upton (R-MI-06), the Chair of the House Energy and Commerce Committee (which has jurisdiction over authorizing legislation for NIH, CDC, FDA and AHRQ) and Congresswoman Diana DeGette (D-CO-01), a member of the Committee, launched their 21st Century Cures initiative with a...
Dear Research Advocate: Washington isn’€™t ignoring research; far from it. Legislation was recently signed into law that allows appropriators to reallocate federal funding from the Republican and Democratic conventions to children’€™s health research; proposals have been introduced that could ultimately provide supplemental federal funding streams for the National Institutes of Health (NIH), the Centers of Disease Control and Prevention (CDC), and several other health research programs; and some Members of Congress have once again launched an attack on the National Science Foundation, demonizing certain projects as a means of casting doubt on scientific freedom. Unless you’€™re playing...
Dear Research Advocate: The budget and appropriations process typically reveals stark differences in funding priorities among the two parties. And this year is no exception. House Budget Committee Ranking Member Chris Van Hollen (D-MD-08) introduced the Democrats’€™ 10-year budget plan this week, which stands apart from the Republican proposal introduced by Chairman Paul Ryan (R-WI-01) most notably by ending sequestration. The Ryan budget, which won House approval today, is on its way to the Senate but is considered dead on arrival. Note that there’€™s still time to urge your Members of Congress to support medical and health research as this year’€™s appropriations process continues! Teen...
Research!America and partners launch national voter education initiative to elevate the priority of medical progress ALEXANDRIA, Va. ’€” April 8, 2014 ’€”Two-thirds of Americans (66%) say it’€™s important for candidates running for office to assign a high priority to funding medical research, according to America Speaks , Volume 14, a compilation of key questions from public opinion polls commissioned by Research!America. Polling shows that Americans place a high value on U.S. leadership in medical innovation, yet only 12% say they are very well informed about the positions of their senators and representative when it comes to their support of medical and scientific research. www...
By Bill Leinweber, President of the National Disease Research Interchange The National Disease Research Interchange (NDRI) is a 501 (c)(3) national organization based in Philadelphia. NDRI is a national leader in the procurement and distribution of human organs, cells and tissues to support the advancement of medical and health research. The NIH has provided funding to NDRI since 1987, and the organization serves over 100 corporate partners. Researchers in academic medical centers, nonprofit research organizations, as well as pharmaceutical, biotechnology and medical device companies rely on NDRI for access to quality human biospecimens and data. NDRI distributes more than 20,000...
Research!America members and partners extend warm congratulations to Research!America Chair The Honorable John Edward Porter for his well-deserved recognition by the National Institutes of Health (NIH) with the dedication of the Porter Neuroscience Research Center. Our nation has benefited from Mr. Porter’s leadership in advancing medical and health research as chair of the House Appropriations Subcommittee on Labor, Health and Human Services, and Education during his tenure in Congress, and as an indomitable force in the research advocacy community. As a U.S. representative, he worked across the aisle to cultivate champions for research, articulating the societal and economic benefits of...
Reps. Wolf and Fattah to Receive the Edwin C. Whitehead Award for Medical Research Advocacy at Research!America’€™s Advocacy Awards Dinner on March 12 ALEXANDRIA, Va. - February 12, 2014 -Reps. Frank Wolf (R-VA) and Chaka Fattah (D-PA) will receive the Edwin C. Whitehead Award for Medical Research Advocacy for their leadership and unwavering commitment to supporting policies that promote federal and private sector medical research and innovation. Reps. Wolf and Fattah have spearheaded efforts to create a legislative and regulatory climate conducive to medical innovation. “Representatives Wolf and Fattah are exceptional champions for research,” said Research!America Chair John Edward Porter...

Pages

Sidebar Quote

Luck shouldn't play a role in why I'm alive.
Laurie MacCaskill, a seven-year pancreatic cancer survivor